Cytodyn Inc (CYDY)

[BioSpecialist]

HGEN or CYDY ...looks like HGENs lenzilumab is very effective as a covid 19 treatment which is in FINAL phase 3 trial with data coming in short term . HGEN is much cheaper than CYDY ..


Therapeutics with the best data reported in the past month are remdesivir, lenzilumab and dexamethasone.

Humanigen Inc., however, reported in June that its Humaneered anti-human-GM-CSF monoclonal antibody lenzilumab led to a median time to improvement and recovery in 12 patients of five days vs. the 10 to 11 days with remdesivir. Although it is a small victory as part of a compassionate use program, all eyes will be on the company’s phase III trial currently enrolling 238 hospitalized COVID-19 pneumonia patients.


https://www.bioworld.com/articles/436226-snowballing-research-preps-avalanche-to-bury-covid-19